Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells
- PMID: 11439329
- DOI: 10.1038/sj.onc.1204480
Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells
Abstract
Increases in abundance of cathepsin B transcript and protein correlate with increases in tumor grade and alterations in subcellular localization and activity of cathepsin B. The enzyme is able to degrade the components of the extracellular matrix (ECM) and activate other proteases capable of degrading ECM. To investigate the role played by this protease in the invasion of brain tumor cells, we transfected SNB19 human glioblastoma cells with a plasmid containing cathepsin B cDNA in antisense orientation. Control cells were transfected with vector alone. Clones expressing antisense cathepsin B cDNA exhibited significant reductions in cathepsin B mRNA, enzyme activity and protein compared to controls. Matrigel Invasion assay showed that the antisense-transfected cells had a markedly diminished invasiveness compared with controls. When tumor spheroids containing antisense transfected SNB19 cells expressing reduced cathepsin B were co-cultured with fetal rat brain aggregates, invasion of fetal rat brain aggregates was significantly reduced. Green Fluorescent Protein (GFP) expressing parental cells and antisense transfectants were generated for detection in mouse brain tissue without any post-chemical treatment. Intracerebral injection of SNB19 stable antisense transfectants resulted in reduced tumor formation in nude mice. These results strongly support a role for cathepsin B in the invasiveness of human glioblastoma cells and suggest cathepsin B antisense may prove useful in cancer therapy.
Similar articles
-
Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.Clin Cancer Res. 2001 Aug;7(8):2519-26. Clin Cancer Res. 2001. PMID: 11489835
-
Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.Oncogene. 2002 Dec 12;21(57):8705-12. doi: 10.1038/sj.onc.1205949. Oncogene. 2002. PMID: 12483523
-
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.Cancer Res. 2000 Dec 15;60(24):6851-5. Cancer Res. 2000. PMID: 11156378
-
Cathepsin B and cystatins: evidence for a role in cancer progression.Semin Cancer Biol. 1990 Apr;1(2):137-52. Semin Cancer Biol. 1990. PMID: 2103490 Review.
-
Cathepsin B and human tumor progression.Biol Chem. 1998 Feb;379(2):113-23. Biol Chem. 1998. PMID: 9524062 Review.
Cited by
-
Host-Parasite Interaction of Atlantic salmon (Salmo salar) and the Ectoparasite Neoparamoeba perurans in Amoebic Gill Disease.Front Immunol. 2021 May 31;12:672700. doi: 10.3389/fimmu.2021.672700. eCollection 2021. Front Immunol. 2021. PMID: 34135900 Free PMC article.
-
Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia.Am J Cancer Res. 2019 Dec 1;9(12):2634-2649. eCollection 2019. Am J Cancer Res. 2019. PMID: 31911851 Free PMC article.
-
Cathepsin B as a cancer target.Expert Opin Ther Targets. 2013 Mar;17(3):281-91. doi: 10.1517/14728222.2013.740461. Epub 2013 Jan 8. Expert Opin Ther Targets. 2013. PMID: 23293836 Free PMC article. Review.
-
IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.Neoplasia. 2013 May;15(5):554-67. doi: 10.1593/neo.13212. Neoplasia. 2013. PMID: 23633927 Free PMC article.
-
Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes.Biochem J. 2002 Oct 1;367(Pt 1):209-17. doi: 10.1042/BJ20020210. Biochem J. 2002. PMID: 12086583 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical